Stay updated on Nicotinamide Riboside in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.

Latest updates to the Nicotinamide Riboside in Heart Failure Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedSite framework updated to version 3.5.0, replacing the previous revision 3.4.3.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This is an administrative metadata change.SummaryDifference0.0%

- Check50 days agoChange DetectedFooter now shows Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedMinor version update from v3.4.0 to v3.4.1 with no substantive content changes visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedUI updates include a glossary toggle and QC milestone timestamps (First Submitted that Met QC Criteria, Results First Submitted that Met QC Criteria, Last Update Submitted that Met QC Criteria) along with a site revision/version notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision: v3.3.4 has been added and v3.3.3 removed. This is a minor administrative update and does not affect study content, results, or interpretation.SummaryDifference0.0%

Stay in the know with updates to Nicotinamide Riboside in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.